PRGO
PERRIGO Co plc
Overview
Perrigo manufactures and markets over-the-counter self-care products sold under both store brands and owned brands to retailers, wholesalers, and consumers in North America and Europe.
PERRIGO Co plc is a Healthcare company operating in Drug Manufacturers - Specialty & Generic with a $1.33B market cap.
Most recent reported earnings: Q2 FY2026 (Jul 30, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-067 Q&A exchanges
- Q4 FY2025Earnings2026-02-2610 Q&A exchanges
- Q3 FY2025Earnings2025-11-0510 Q&A exchanges
- Q2 FY2025Earnings2025-08-069 Q&A exchanges
- Q1 FY2025Earnings2025-05-0714 Q&A exchanges
- Q4 FY2024Earnings2025-02-2810 Q&A exchanges
- Q3 FY2024Earnings2024-11-0612 Q&A exchanges
- Q2 FY2024Earnings2024-08-0213 Q&A exchanges
- Q1 FY2024Earnings2024-05-0711 Q&A exchanges
- Q4 FY2023Earnings2024-02-2715 Q&A exchanges
- Q3 FY2023Earnings2023-11-0714 Q&A exchanges
- Q2 FY2023Earnings2023-08-089 Q&A exchanges
- Q1 FY2023Earnings2023-05-0913 Q&A exchanges
- Q4 FY2022Earnings2023-02-2813 Q&A exchanges
- Q3 FY2022Earnings2022-11-0814 Q&A exchanges
- Q2 FY2022Earnings2022-08-0912 Q&A exchanges
- Q1 FY2022Earnings2022-05-1118 Q&A exchanges
- Q4 FY2021Earnings2022-03-0113 Q&A exchanges
- Q3 FY2021Earnings2021-11-1014 Q&A exchanges
- Q2 FY2021Earnings2021-08-1111 Q&A exchanges
- Q1 FY2021Earnings2021-05-1110 Q&A exchanges
History
Earnings history
- Q2 FY20262026-07-30EPS— vs $0.36—Rev— vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-07-30 | — | $0.36 | — | — | — | — | EODHD |
Source: EODHD. PRGO reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks PRGO's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 70% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $2.01 | $1.40 | +43.9% | +1.1% | +2.2% |
| Q4 FY2026 | $2.12 | $1.48 | +43.4% | -1.4% | -1.1% |
| Q3 FY2026 | $1.94 | $1.50 | +29.2% | +8.1% | +7.4% |
| Q2 FY2026 | $2.27 | $1.72 | +31.8% | -3.0% | -1.1% |
| Q1 FY2025 | $2.30 | $1.60 | +43.9% | +3.1% | +5.1% |
| Q4 FY2025 | $2.19 | $1.51 | +45.0% | +8.1% | +7.2% |
| Q3 FY2025 | $2.61 | $1.80 | +45.0% | +4.7% | +3.5% |
| Q2 FY2025 | $2.31 | $1.71 | +34.9% | -0.6% | +2.2% |
| Q1 FY2024 | $2.44 | $1.75 | +39.2% | +7.8% | +5.7% |
| Q4 FY2024 | $2.46 | $1.81 | +35.8% | +7.8% | +10.0% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Patrick Lockwood-taylorCEO1 yr10 callsCurrentSample
CEO since 2025 • 3/4 beats (75%) • guidance suspended Q2 FY2026
- Eduardo Guarita BezerraCFO1 yr1 callCurrentSample
CFO since 2025 • 3/4 beats (75%) • last guidance raise Q3 FY2026
- Triona SchmelterPresident1 yrno recorded callsCurrentSample
PRESIDENT since 2025 • 3/4 beats (75%) • guidance suspended Q1 FY2026
- Roberto KhouryPresident1 yr 10 mo1 callCurrentSample
PRESIDENT since 2024 • 7/8 beats (88%) • guidance suspended Q3 FY2026
- Abigail LennoxEVP and CSO1 yrno recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 3/4 beats (75%) • guidance suspended Q1 FY2026
- Robert WillisEVP & CHRO1 yrno recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last guidance raise Q2 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for PRGO.
$ curl https://api.spokenalpha.com/v1/companies/PRGOFAQ
Frequently asked about PRGO
Where can I find PERRIGO Co plc's (PRGO) earnings call transcripts?
Spoken Alpha indexes PRGO's earnings call transcripts at https://spokenalpha.com/companies/PRGO. Each call links to attributed speakers and parsed analyst Q&A. PERRIGO Co plc's own investor relations page is at https://investor.perrigo.com/.
When was PERRIGO Co plc's most recent earnings call?
PERRIGO Co plc (PRGO) held its most recent earnings call on 2026-05-06, covering fiscal Q1 2026.
What sector is PRGO in?
PERRIGO Co plc (PRGO) operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).